T2 Biosystems, Inc.
Hedge Funds Holdings
Last updated:
T2 Biosystems, Inc.‘s stocks are currently a part of 68 hedge funds’ portfolios, which represents 9.63% of the total amount of its stocks outstanding. This makes up a total of 15.30M shares of T2 Biosystems, Inc.. Compared to the previous quarter, the number fell by -20.32% or -3.90M shares fewer. As for the holding position changes, 22.06% (15) of current hedge fund investors increased the number of shares held, 26.47% (18) of current holders sold a part of the shares held, and 10.29% (7) closed the holdings completely. 2 hedge funds are new holders of T2 Biosystems, Inc. stock in Q1 2022, it is 2.94% of total holders.
Hedge funds holding T2 Biosystems (Q2 2017 – Q1 2022)
Q2 2017 | 43 |
---|---|
Q3 2017 | 44 |
Q4 2017 | 45 |
Q1 2018 | 55 |
Q2 2018 | 101 |
Q3 2018 | 96 |
Q4 2018 | 96 |
Q1 2019 | 79 |
Q2 2019 | 67 |
Q3 2019 | 52 |
Q4 2019 | 47 |
Q1 2020 | 40 |
Q2 2020 | 49 |
Q3 2020 | 57 |
Q4 2020 | 64 |
Q1 2021 | 78 |
Q2 2021 | 80 |
Q3 2021 | 76 |
Q4 2021 | 74 |
Q1 2022 | 68 |
Hedge funds changes in T2 Biosystems positions (Q2 2017 – Q1 2022)
Q2 2017 | 15 | 10 | 11 | 18 | -11 |
---|---|---|---|---|---|
Q3 2017 | 11 | 13 | 9 | 9 | 2 |
Q4 2017 | 9 | 14 | 9 | 8 | 5 |
Q1 2018 | 15 | 18 | 12 | 5 | 5 |
Q2 2018 | 55 | 24 | 13 | 9 | 0 |
Q3 2018 | 17 | 43 | 22 | 22 | -8 |
Q4 2018 | 14 | 35 | 22 | 13 | 12 |
Q1 2019 | 10 | 28 | 22 | 26 | -7 |
Q2 2019 | 16 | 17 | 16 | 23 | -5 |
Q3 2019 | 9 | 16 | 14 | 24 | -11 |
Q4 2019 | 9 | 13 | 15 | 14 | -4 |
Q1 2020 | 8 | 17 | 6 | 12 | -3 |
Q2 2020 | 16 | 12 | 12 | 7 | 2 |
Q3 2020 | 15 | 18 | 8 | 7 | 9 |
Q4 2020 | 18 | 20 | 11 | 12 | 3 |
Q1 2021 | 23 | 23 | 19 | 8 | 5 |
Q2 2021 | 12 | 21 | 19 | 10 | 18 |
Q3 2021 | 9 | 18 | 18 | 11 | 20 |
Q4 2021 | 9 | 18 | 18 | 12 | 17 |
Q1 2022 | 2 | 15 | 18 | 7 | 26 |
Hedge funds changes in T2 Biosystems stock options (Q2 2017 – Q1 2022)
Q2 2017 | 0 | 4,000 |
---|---|---|
Q3 2017 | 0 | 51,000 |
Q4 2017 | 289,000 | 57,000 |
Q1 2018 | 452,000 | 472,000 |
Q2 2018 | 2,360,000 | 1,465,000 |
Q3 2018 | 1,094,000 | 957,000 |
Q4 2018 | 204,000 | 305,000 |
Q1 2019 | 236,000 | 431,000 |
Q2 2019 | 260,000 | 171,000 |
Q3 2019 | 437,000 | 200,000 |
Q4 2019 | 70,000 | 102,000 |
Q1 2020 | 33,000 | 52,000 |
Q2 2020 | 553,000 | 218,000 |
Q3 2020 | 611,000 | 363,000 |
Q4 2020 | 333,000 | 344,000 |
Q1 2021 | 1,228,000 | 926,000 |
Q2 2021 | 659,000 | 546,000 |
Q3 2021 | 470,000 | 379,000 |
Q4 2021 | 280,000 | 177,000 |
Q1 2022 | 191,000 | 122,000 |